Metastatic liver tumors Academic Article Article uri icon

Overview

MeSH Major

  • Bile Duct Neoplasms
  • Bile Ducts, Extrahepatic
  • Cholangiocarcinoma
  • Neoplasm Staging
  • Preoperative Care

abstract

  • The liver is a common site of metastasis from a variety of tumors. In many cases, liver resection for metastatic cancer provides the only chance for a cure and can be performed with less than 5% mortality and acceptable morbidity. The 5-year survival following liver resection for colorectal metastasis is reported in many large series to be 25% to 37%. The data regarding liver resection for other metastatic tumor types are less clear. However, resection for selected tumors, such as neuroendocrine and renal cell, can provide durable palliation and/or cure. We will review important prognostic factors used to guide the selection of patients for resection of metastatic disease and make recommendations for imaging studies and follow-up routines. The role of adjuvant regional and systemic chemotherapy for resectable metastatic disease is also discussed. Methods for ablating unresectable metastatic tumors may prove to be useful adjuncts to current therapies.

publication date

  • November 20, 2000

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

PubMed ID

  • 11126381

Additional Document Info

start page

  • 177

end page

  • 88

volume

  • 19

number

  • 2